Judge holds up Teva's $85M opioid settlement, sinking shares back to pre-2000 levels

Teva made headlines late last month when it inked an $85 million settlement with Oklahoma prosecutors over opioid mismarketing allegations—even after CEO Kåre Schultz said the company wouldn't strike big settlement deals in the ongoing opioid litigation.

Now, an Oklahoma judge in the state has refused to sign off on the deal until he gets more information about how it complies with a new state law, AP reports.